A Study to Evaluate the Efficacy and Safety of Combination of Oral and Parenteral Vinorelbine with Cisplatin or Carboplatin in Patients With Non Small Cell Lung Cancer (NSCLC)

Trial Profile

A Study to Evaluate the Efficacy and Safety of Combination of Oral and Parenteral Vinorelbine with Cisplatin or Carboplatin in Patients With Non Small Cell Lung Cancer (NSCLC)

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Jan 2016

At a glance

  • Drugs Carboplatin (Primary) ; Cisplatin (Primary) ; Vinorelbine (Primary) ; Vinorelbine (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SWITCH
  • Most Recent Events

    • 18 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top